Home › Compare › RPGLF vs JNJ

RPGLF vs JNJ: Dividend Comparison 2026

RPGLF yields 33898.31% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RPGLF wins by $9.963396520724352e+21M in total portfolio value
10 years
RPGLF
RPGLF
● Live price
33898.31%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.963396520724352e+21M
Annual income
$9,905,911,559,981,649,000,000,000,000.00
Full RPGLF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RPGLF vs JNJ

📍 RPGLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRPGLFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RPGLF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RPGLF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RPGLF
Annual income on $10K today (after 15% tax)
$2,881,355.93/yr
After 10yr DRIP, annual income (after tax)
$8,420,024,825,984,401,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, RPGLF beats the other by $8,420,024,825,984,401,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RPGLF + JNJ for your $10,000?

RPGLF: 50%JNJ: 50%
100% JNJ50/50100% RPGLF
Portfolio after 10yr
$4.981698260362176e+21M
Annual income
$4,952,955,779,990,824,000,000,000,000.00/yr
Blended yield
99.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RPGLF
No analyst data
Altman Z
-55.1
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RPGLF buys
0
JNJ buys
0
No recent congressional trades found for RPGLF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRPGLFJNJ
Forward yield33898.31% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$9.963396520724352e+21M$20.0K ✓
Annual income after 10y$9,905,911,559,981,649,000,000,000,000.00 ✓$827.78
Total dividends collected$9.959616773768018e+21M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RPGLF vs JNJ ($10,000, DRIP)

YearRPGLF PortfolioRPGLF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$3,400,531$3,389,830.51$10,676$355.77+$3.39M → RPGLF
2$1,080,949,041$1,077,310,473.14$11,407$389.39+$1080.94M → RPGLF
3$321,205,007,173$320,048,391,699.27$12,198$426.53+$321204.99M → RPGLF
4$89,224,694,578,678$88,881,005,221,002.70$13,056$467.62+$89224694.57M → RPGLF
5$23,169,738,996,241,900$23,074,268,573,042,710.00$13,987$513.12+$23169738996.23M → RPGLF
6$5,624,691,175,493,529,000$5,599,899,554,767,550,000.00$14,998$563.56+$5624691175493.51M → RPGLF
7$1,276,516,462,323,700,300,000$1,270,498,042,765,922,300,000.00$16,098$619.52+$1276516462323700.25M → RPGLF
8$270,840,549,707,403,520,000,000$269,474,677,092,717,130,000,000.00$17,295$681.69+$270840549707403520.00M → RPGLF
9$53,724,262,376,359,350,000,000,000$53,434,462,988,172,430,000,000,000.00$18,599$750.82+$53724262376359346176.00M → RPGLF
10$9,963,396,520,724,353,000,000,000,000$9,905,911,559,981,649,000,000,000,000.00$20,022$827.78+$9.963396520724352e+21M → RPGLF

RPGLF vs JNJ: Complete Analysis 2026

RPGLF — Stock

Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services.

Full RPGLF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RPGLF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RPGLF vs SCHDRPGLF vs JEPIRPGLF vs ORPGLF vs KORPGLF vs MAINRPGLF vs ABBVRPGLF vs MRKRPGLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.